or Proteus mirabilis in adult women who have limited or no alternative oral antibacterial treatment options. This is the first approved indication for Orlynvah and the first FDA-approved product ...

Bacterial pathogens isolated were Escherichia coli (41.48%), Staphylococcus saprophyticus (30.55%), Proteus mirabilis (13.85%), Pseudomonas aeruginosa (8.68%) and Klebsiella aerogenes (5.47%). Among ...

Bacterial pathogens isolated were Escherichia coli (41.48%), Staphylococcus saprophyticus (30.55%), Proteus mirabilis (13.85%), Pseudomonas aeruginosa (8.68%) and Klebsiella aerogenes (5.47%). Among ...

The US healthcare system’s focus on activity rather than value for money was behind the demise of Proteus Digital Health and its “digital pill”, which measured whether schizophrenia patients ...

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has ...

Purpose. The chemistry, pharmacology, antimicrobial activity, pharmacokinetics, pharmacodynamics, efficacy and safety in humans, and formulary considerations of doripenem are reviewed. Summary ...

NT: Not tested; TCID: Tissue culture infectious dose. 2 Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia 3 Department of Medical ...

NEW research highlights the role of ventilator-capable nursing homes in the spread of antimicrobial-resistant pathogens, including the emerging multidrug-resistant fungus Candida auris, reinforcing ...